From bases to breakthroughs: Editing cancer’s weak spots with CRISPR

2026-05-26T13:53:09+01:0026 May 2026|

In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founder of BASE Rx alongside Group Leader, Dr Mathew Garnett.

Building a community at the frontline of cholera genomics

2025-09-04T14:01:06+01:004 September 2025|

In this eighth part of our innovator blog series, we spoke to Dr Jolynne Mokaya, Public Health Lead at the Wellcome Sanger Institute. With an entrepreneurial and ingenious spirit, Jolynne is helping to build a community of practice of cholera experts that will facilitate and progress research by leveraging regional expertise across several continents.

Bugs as drugs – Innovating in the Microbiome space

2025-05-06T12:41:28+01:006 May 2025|

We spoke to Dr Trevor Lawley, Senior Group Leader at the Wellcome Sanger Institute who works in the Parasites and Microbes Programme.  Trevor’s is the story of turning basic, fundamental research into innovative science with potential to treat a broad range of human diseases.

Microbiotica: CASE STUDY

2025-01-16T14:21:41+00:001 December 2024|

Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.

Join us for the Explainable AI in Biology Conference

2024-12-18T16:13:22+00:002 September 2024|

Science and AI fans, get ready for October 2024 – the Wellcome Sanger Institute is hosting the first-ever Explainable AI in Biology Conference at the Wellcome Genome Campus. Here we review a snapshot of some of the planned talks from AI experts about integrating AI into biological research.

Sanger’s startup school envigorates future entrepreneurs

2024-07-05T10:06:23+01:0011 June 2024|

The fourth edition of Sanger’s Startup School closed with 30 participants from the Wellcome Sanger Institute and EMBL-EBI having gained the confidence to look at science with a different, entrepreneurial perspective.

Tackling trypanosomiasis in cattle in sub-Saharan Africa

2024-07-05T10:40:12+01:006 February 2024|

Three vaccine targets discovered by the Wellcome Sanger Institute focus on targeting animal trypanosomiasis in an effort to find a cure for a disease that causes billions in economic losses in one of the poorest regions on earth. These losses fall heavily on small holders, who are often heavily dependent on livestock for their livelihood.